What is Vineet Laboratories share price return in the past 10 years?

Data is not available for this company

Vineet Laboratories Ltd - Stock Valuation and Financial Performance

Name: Vineet Laboratories
Brand: Vineet Laboratories

BSE: 543298 | NSE: VINEETLAB | Pharmaceuticals & Drugs | Small Cap

Place order

Vineet Laboratories Share Price

₹50.75 0.20 0.40%
as on 19-Apr'24 16:01

DeciZen - make an informed investing decision on Vineet Laboratories

Based on:

Data

M-Cap below 100cr DeciZen not available

Vineet Laboratories stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

17.66

Market Cap:

46.8 Cr.

52-wk low:

45.7

52-wk high:

Is Vineet Laboratories Ltd an attractive stock to invest in?

1. Is Vineet Laboratories Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Vineet Laboratories Ltd is a below average quality company.

2. Is Vineet Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Vineet Laboratories Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Vineet Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vineet Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Vineet Laboratories:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	0%	0%	-2.8%	17.5%	16.3%	6.2%	-
Value Creation Index ⓘ	NA	NA	-1.2	0.3	0.2	-0.6	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	243	191	212	171
Sales YoY Gr.	-	NA	NA	NA	-21.5%	11.1%	-
Adj EPS ⓘ	0	0	-0.3	1.7	7.1	1.6	2.9
YoY Gr.	-	NA	NA	NA	314.5%	-77.3%	-
BVPS (₹) ⓘ	-3.9	9.1	9.7	28.9	36	36.5	35.6
Adj Net Profit ⓘ	0	0	0	1.6	6.6	1.5	3
Cash Flow from Ops. ⓘ	0	0	0	27.5	7.6	-9.6	-
Debt/CF from Ops. ⓘ	0	0	0	0.5	3.5	-3.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	NA	11.1%
Adj EPS ⓘ	NA	NA	NA	-77.3%
BVPSⓘ	NA	NA	55.4%	1.4%
Share Price	-	-	-	3.8%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	-2.8	11.8	22	4.5	8
Op. Profit Mgn % ⓘ	0	3.4	6.9	3.8	5.6
Net Profit Mgn % ⓘ	0	0.7	3.4	0.7	1.6
Debt to Equity ⓘ	0	0.5	0.8	0.9	-
Working Cap Days ⓘ	0	65	172	156	131
Cash Conv. Cycle ⓘ	0	18	32	51	20

Recent Performance Summary

Debt to equity has declined versus last 3 years average to 0.92

Return on Equity has declined versus last 3 years average to 8.00%

Sales growth has been subdued in last 3 years 0.00%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at -15.40%

Latest Financials - Vineet Laboratories Ltd.

	Standalone	Consolidated
TTM EPS (₹)	2.9	-
TTM Sales (₹ Cr.)	171	-
BVPS (₹.) ⓘ	35.6	-
Reserves (₹ Cr.) ⓘ	24	-
P/BV ⓘ	1.43	-
PE ⓘ	17.66	-

From the Market
52 Week Low / High (₹)	45.65 / 88.95
All Time Low / High (₹)	38.20 / 124.70
Market Cap (₹ Cr.)	46.8
Equity (₹ Cr.)	9.2
Face Value (₹)	10
Industry PE ⓘ	47.2

Management X-Ray of Vineet Laboratories:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Vineet Laboratories

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Vineet Laboratories

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	0	0	0	243.48	191.17	212.29
Operating Expenses ⓘ	0	0	0.01	235.33	178.01	204.63
Manufacturing Costs	0	0	0	26.52	18.83	18.28
Material Costs	0	0	0	198.11	145.55	172.33
Employee Cost	0	0	0	5.57	4.91	4.90
Other Costs ⓘ	0	0	0.01	5.13	8.73	9.13
Operating Profit ⓘ	0	0	-0.01	8.15	13.16	7.66
Operating Profit Margin (%)	-	-	-	3.3%	6.9%	3.6%
Other Income ⓘ	0	0	0	0.39	0.29	0.12
Interest ⓘ	0	0	0	2.67	2.09	3.38
Depreciation ⓘ	0	0	0	1.81	2.02	2.37
Exceptional Items ⓘ	0	0	0	0	0	0
Profit Before Tax ⓘ	0	0	-0.01	4.06	9.35	2.03
Tax ⓘ	0	0	0	2.28	2.71	0.78
Profit After Tax	0	0	-0.01	1.78	6.64	1.25
PAT Margin (%)	-	-	-	0.7%	3.5%	0.6%
Adjusted EPS (₹)	0.0	0.0	-0.3	1.9	7.2	1.4
Dividend Payout Ratio (%)	0%	0%	0%	0%	14%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	0.01	0.41	0.40	26.62	33.22	33.68
Share Capital ⓘ	0.01	0.41	0.41	9.22	9.22	9.22
Reserves ⓘ	0	0	-0.01	17.40	24	24.46
Minority Interest	0	0	0	0	0	0
Debt	0	0	0	12.47	26.51	30.05
Long Term Debt	0	0	0	3.47	1.72	4.85
Short Term Debt	0	0	0	9.01	24.79	25.20
Trade Payables	0.01	0.01	0	55.99	60.09	34.89
Others Liabilities ⓘ	0.01	0	0	13.67	13.49	17.23
Total Liabilities ⓘ	0.02	0.42	0.40	108.74	133.32	115.85
Fixed Assets
Gross Block	0	0	0	35.48	39.22	46.85
Accumulated Depreciation	0	0	0	15.82	17.83	20.21
Net Fixed Assetsⓘ	0	0	0	19.67	21.38	26.65
CWIP ⓘ	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0.12	0.14	0.13
Inventories	0	0	0	39.69	43.54	46.17
Trade Receivables	0	0	0	42.71	36.20	35.16
Cash Equivalents	0	0.01	0	2.10	18.12	0.95
Others Assetsⓘ	0.02	0.41	0.40	4.46	13.94	6.79
Total Assets ⓘ	0.02	0.42	0.40	108.74	133.32	115.85

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	0	27.49	7.63	-9.62
PBT ⓘ	-0.01	4.06	9.35	2.03
Adjustment ⓘ	0	5.71	3.90	6.15
Changes in Working Capital ⓘ	0.01	16.87	-2.43	-14.81
Tax Paid ⓘ	0	0.85	-3.18	-2.99
Cash Flow From Investing Activity ⓘ	0	-7.81	-3.68	-6.69
Capex	0	-7.85	0	-6.81
Net Investments	0	0	-3.84	0
Others ⓘ	0	0.05	0.16	0.12
Cash Flow From Financing Activityⓘ	0	18.62	11.96	0.27
Net Proceeds from Shares ⓘ	0	8.81	0	0
Net Proceeds from Borrowing ⓘ	0	0	14.04	4.17
Interest Paid ⓘ	0	-2.67	-2.09	-3.38
Dividend Paid ⓘ	0	0	0	-0.92
Others ⓘ	0	12.47	0	0.41
Net Cash Flow ⓘ	0	38.30	15.91	-16.03

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	0	0	-2.87	13.18	22.19	3.74
ROCE (%)	0	0	-2.87	34.06	23.14	8.69
Asset Turnover Ratio	0	0	0	4.46	1.58	1.7
PAT to CFO Conversion(x)	N/A	N/A	N/A	15.44	1.15	-7.7
Working Capital Days
Receivable Days	0	0	0	64	75	61
Inventory Days	0	0	0	59	79	77
Payable Days	0	0	0	52	146	101

Vineet Laboratories Ltd Stock News

Vineet Laboratories Ltd FAQs

What is the share price of Vineet Laboratories?

Company share prices are keep on changing according to the market conditions. The closing price of Vineet Laboratories on 19-Apr-2024 16:01 is ₹50.75.

What is the market cap of Vineet Laboratories?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 19-Apr-2024 16:01 the market cap of Vineet Laboratories stood at ₹46.79.

What is the P/E ratio of Vineet Laboratories?

The latest P/E ratio of Vineet Laboratories as of 19-Apr-2024 16:01 is 17.66.

What is the P/B ratio of Vineet Laboratories?

The latest P/B ratio of Vineet Laboratories as of 19-Apr-2024 16:01 is 1.43.

What is the 52-week high and low of Vineet Laboratories?

The 52-week high of Vineet Laboratories is ₹88.95 and the 52-week low is ₹45.65.

What is the TTM revenue of Vineet Laboratories?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vineet Laboratories is ₹170.7 ( Cr.) .

About Vineet Laboratories Ltd

Vineet Laboratories Limited (Formerly Known As Ortin Laboratories Limited, Unit-II) is public company domiciled in India and incorporated under the provisions of Companies Act, 2013 applicable in India and it was incorporated in India on November 10, 2016 having its Registered office at Saheb Nagar, Kurdu Vill, Chintal Kunta, Eshwaramma Nilayam, L B Nagar, Hyderabad, Telangana. The shares of the company are listed on Bombay Stock Exchange and National Stock Exchange.

Business area of the company

The company is engaged in the business of Drug Intermediates & Bulk Dugs.

Product and services